JPRN-jRCT2011210013进行中（未招募）未知
43-301 : Special Drug Use-Results Survey of ONGENTYS (Long-term observation)
Kuro Toshihiko0 个研究点目标入组 250 人开始时间: 2021年5月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with intra-day fluctuations of symptom in Parkinson's disease (wearing-off phenomenon) under treatment of combination therapy with levodopa/carbidopa or levodopa/benserazide hydrochloride, for whom ONGENTYS is administrated for the first time
排除标准
- •Patients who have received ONGENTYS previously
研究者
相似试验
已完成
Unknown
Special Drug Use-Results Survey of Onoacttachyarrhythmia, atrial fibrillation/atrial flutter in patients with cardiac dysfunctionJPRN-jRCT1080222572ONO PHARMACEUTICAL CO., LTD.800
已完成
Unknown
General Drug Use-Results Survey of Onoact [ ventricular fibrillation and hemodynamically ventricular tachycardia]Ventricular arrhythmiasJPRN-jRCT1080225340ONO PHARMACEUTICAL CO., LTD.200
招募中
不适用
Special Drug Use Results Survey for the use of Symtuza in pregnant womeJPRN-UMIN000037488Janssen Pharmaceutical K.K.3
进行中（未招募）
不适用
Protocol Number; CAIN457L1401JPRN-jRCT2031210589Toshiya Sugimoto35
进行中（未招募）
不适用
40-301 : Special Drug Use-Results Survey of ADLUMIZCancer cachexia: non-small cell lung cancer, gastric cancer, pancreatic cancer, large intestine cancJPRN-jRCT2011210014Kuro Toshihiko5,000